1
Defrees Shawn, Zopf David A, Taudte Susann, Willett W Scott, Bayer Robert J, Kalo Matthew: Glycopegylated factor vii and factor viia. Neose Technologies, Defrees Shawn, Zopf David A, Taudte Susann, Willett W Scott, Bayer Robert J, Kalo Matthew, ESKER Todd W, February 22, 2007: WO/2007/022512 (43 worldwide citation)

The present invention provides conjugates between Factor VII or Factor Vila peptides and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosy ...


2
Defrees Shawn, Clausen Henrik, Zopf David A, Bowe Caryn, Taudte Susann, Felo Michael, Willett Walter S: Glycopegylated granulocyte colony stimulating factor. Neose Technologies, Defrees Shawn, Clausen Henrik, Zopf David A, Bowe Caryn, Taudte Susann, Felo Michael, Willett Walter S, MANN Jeffry S, July 13, 2006: WO/2006/074467 (36 worldwide citation)

The present invention provides conjugates between Granulocyte Colony Stimulating Factor and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glyc ...


3
Johnson Karl F, Chen Xi, Taudte Susann, Saribas Sami: Truncated galnact2 polypeptides and nucleic acids. Neose Technologies, Johnson Karl F, Chen Xi, Taudte Susann, Saribas Sami, KELLY Beth L, December 22, 2005: WO/2005/121331 (34 worldwide citation)

The present invention features compositions and methods related to truncated mutants of GalNAcT2. In particular, the invention features truncated human GalNAcT2 polypeptides. The invention also features nucleic acids encoding such truncated polypeptides, as well as vectors, host cells, expression sy ...